What it's does: The London-based Benevolent AI was founded in 2013. The startup uses AI to advance medical research. It's a rising star in the biotech and drug discovery field.
What it's worth now: $2 billion
Total funding: $203 million
Who's invested: BenevolentAI has been funded by private equity since the beginning. In April, it raised $115 million from investors at Lansdowne Partners, Lundbeck, Nortrust Nominees, Upsher-Smith Laboratories and Woodford Investment Management.